ISCO Scientists to Present Results of Recent Stem Cell Research on Parkinson's Disease at Annual Meeting of American Academy of Neurology
CARLSBAD, Calif., Apr 23, 2012 (BUSINESS WIRE) -- International Stem Cell Corporation (ISCO.OB),
www.internationalstemcell.com , today announced that several of its senior scientists, led by Dr. Ruslan Semechkin Vice President Research and Development, will present the results of their most recent experiments on the therapeutic use of human parthenogenetic stem cells (hpSCs) in Parkinson's disease at the 64th Annual Meeting of American Academy of Neurology in New Orleans (April 21 to 28 2012).